LibrarianMeg said:Omega-3 index improvement on the lipid panel: often overlooked but my omega-3 index went from 3.7% to 8.7% over 8 months.
Tracking labs for the lipid panel — here's the panel I get every 3 months and why:
- CMP: glucose, electrolytes, kidney function, liver enzymes
- Lipid panel: total cholesterol, LDL, HDL, triglycerides
- A1C: 3-month glucose average
- hsCRP: inflammatory marker
- CBC: blood counts, anemia screening
- B12, folate, iron: nutritional deficiency screening
- TSH, free T4: thyroid monitoring
- Lipase: pancreatic safety check
Total cost with insurance: about $40 copay. Without insurance, request cash-pay pricing from Quest/Labcorp — usually $185.
LabKate said:Fair, but phase 2 tolerability figures rarely survive contact with phase 3 scale.
Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.
LibrarianMeg said:Omega-3 index improvement on the lipid panel: often overlooked but my omega-3 index went from 3.7% to 8.7% over 8 months.
I would rather people stopped quoting the 24% as if it were a licensed outcome. It is a phase 2 result in a few hundred participants with no cardiovascular endpoint and no long-term safety data, and this board has a habit of treating pipeline numbers as settled.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL Biochemjennifer_SEA said:Trying to work out whether my panel improved or merely rearranged itself, because two of the numbers went the wrong way.
Advanced lipoprotein testing on the lipid panel — going beyond standard lipid panel:
| Marker | Baseline | Month 8 | Clinical Meaning |
|---|---|---|---|
| LDL-P | 1635 | 935 | Particle count (more precise than LDL-C) |
| Small dense LDL | 55% | 31% | Atherogenic pattern |
| Remnant cholesterol | 35 | 14 | Triglyceride-rich lipoproteins |
| oxLDL | 80 | 43 | Oxidative stress marker |
The shift from small dense to large buoyant LDL is particularly important — it represents a fundamental change in the atherogenic profile.
Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.